|
Jan 10
|
ImmunoPrecise Antibodies Reports A 19.9% Revenue Increase As It Launches The Next Phase Of LENSai Portal And SaaS Platforms
|
|
Dec 19
|
ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q2 2024 Earnings Call Transcript
|
|
Dec 8
|
IPA Announces Closing of $1.265 Million Public Offering of Common Shares
|
|
Dec 7
|
ImmunoPrecise Antibodies Welcomes Mitch Levine To Its Board Of Directors, To Announce Quarterly Results On December 14
|
|
Dec 6
|
IPA Announces Pricing of $1.1 Million Public Offering of Common Shares
|
|
Dec 5
|
IPA Announces Proposed Public Offering of Common Shares
|
|
Nov 27
|
ImmunoPrecise Antibodies Ltd. Announces Key Board and Board Committee Chair Appointments and Second Quarter 2024 Earnings Release Call
|
|
Jun 29
|
IPA to Report Financial Results and Recent Business Highlights for Fourth Quarter and Fiscal Year End 2023 on July 7th, 2023.
|